The growth of Viagra and its influence on the medicinal landscape presents a intricate question for investors. While the initial sales statistics were remarkable, the patent has expired, leading to a wave of copycat alternatives that are chipping away at profit. Moreover, the market is facing challenges related to population trends and shifting hea